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Abstract 
Esophageal cancer most commonly presents with upper digestive symptoms such as 
dysphagia. Lymph nodes are among the most common metastatic sites of this type of 
cancer. We report the case of a 53-year-old man presenting with unusual sole presenting 
features of esophageal cancer. The patient sought medical attention for abdominal pain 
without dysphagia, which was first investigated with an abdominal computed tomography 
scan. A large abdominal mass was discovered on imaging. Biopsies of this mass were in 
keeping with esophageal squamous cell cancer. With this finding, gastroscopy was 
performed, confirming the presence of primary esophageal cancer. This is a rare 
presentation of esophageal cancer without upper gastrointestinal symptoms. This case 
reinforces the value of biopsy for any neoplastic mass, especially in a context of unusual 
symptoms. 
 
Introduction 
Esophageal cancer is the fifth leading cause of death in men from cancer worldwide 
[1]. In 2009 in Canada, there were 1,600 estimated new cases of esophageal cancer, 
representing less than 1% of the 2008 anticipated incidence of cancer. Men were more 
affected with 1,200 estimated new cases [2]. The median age at diagnosis is 68 years 
[3]. 
There are two majors types of esophageal cancer: esophageal squamous cell cancer 
(ESCC) and esophageal adenocarcinoma (EAC). Together, they represent more than 
90% of primary esophageal carcinomas. There are numerous identifiable risk factors. 
Tobacco use and previous radiotherapy for breast cancer are major know risk factors 
for both EAC and ESCC [4]. ESCC risk is also increased with alcohol consumption,  
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caustic injury to the esophagus, achalasia, tylosis (nonepidermolytic palmoplantar 
keratoderma), Plummer-Vinson syndrome and a history of head and neck cancer. The 
known risk factors for EAC are chronic gastroesophageal reflux disease and Barrett’s 
esophagus [5].  
Clinical presentation is similar for all types of esophageal cancers. The most common 
symptoms are dysphagia and odynophagia [1]. Other less common ones include 
hoarseness, cough and dyspnea [4]. More than a third of patients with ESCC present 
with metastatic disease. The metastases are usually in the lymph nodes, liver, lungs and 
bones [1]. 
The initial investigation includes an upper endoscopy or a barium-swallow exam. 
To exclude metastasis, a computed tomography (CT) scan of the chest, abdomen and 
pelvis should be performed [4]. The stages of esophageal cancer are defined according 
to the American Joint Committee on Cancer Staging system. Treatment is based on this 
staging and includes endoscopic mucosal resection, surgery, radiotherapy and 
chemotherapy [5]. 
Case Report 
A 53-year-old Caucasian man sought medical attention for a 4-week history of upper abdominal 
pain. He had no medical history besides chronic drinking for 35 years and active smoking of 25 packs 
per year. He denied having any abdominal symptoms in the past. The pain was constant and located in 
the epigastrium, spreading to his back. It was associated with immediate postprandial fullness, nausea 
and vomiting. He denied having dysphagia or odynophagia. Over a period of 3 months, he developed 
anorexia with an aversion to food, drinking only liquids. He lost 40 pounds, which represented 21% of 
his total weight.  
On physical examination, the patient was underweight with normal vital signs. Abdominal 
examination revealed present bowel sounds and an epigastric mass that was firm, fixed and 
non-pulsatile. He did not have abdominal tenderness, organomegaly or adenomegaly. His rectal 
examination was normal. The remainder of the examination was unremarkable.  
Initial laboratory results showed a hemoglobin level of 136 g/l (normal 135–170 g/l) with a 
hematocrit of 39.7% (normal 42–50%). Amylase level was 149 U/l (normal 0–100 U/l) and lipase 
201 U/l (normal 0–60 U/l). The rest of the blood results were all normal. Tumor markers were within 
normal ranges, including carcinogenic embryonic antigen and carbohydrate antigen 19-9. 
A CT scan revealed a heterogeneous lesion with necrotic tissue localized beneath the pancreatic 
gland, at the mesenteric root (fig. 1). The mass was pushing the pancreas forward and was invading 
vascular structures of the celiac trunk and the superior mesenteric artery. Some retroperitoneal 
suspicious lymph nodes were also noted. The rest of the CT was within normal limits, including the 
renal and urinary systems. It was impossible for the radiologists to determine the exact origin of this 
tumor on imaging. 
Considering the retropancreatic localization of the mass, an upper endoscopic ultrasound (EUS) 
was performed to obtain tissue samples for histology. It demonstrated extrinsic compression of the 
stomach along the lesser curvature by this heterogeneous mass, which measured more than 6 cm 
(fig. 2). It was invading the celiac trunk and the superior mesenteric artery, as described on the CT. 
The mass seemed to arise neither from the stomach nor the pancreas. Biopsies were performed by 
EUS-guided transgastric fine-needle aspiration (19-gauge Echotip ultra-endoscopic ultrasound 
needle, Wilson-Cook Medical Inc., 3 passes). The specimen was analyzed by a gastrointestinal 
specialized pathologist and was in keeping with the diagnosis of ESCC. The histology was confirmed 
by an immunohistochemical study with CD117, CD34, CD45, Be 12, Ker7, Ker20, Ker8-18 and 34 
markers.   
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With these findings, an upper gastrointestinal endoscopy was performed. It revealed a 
non-ulcerated suspicious lesion at the mid third of the esophagus, without stenosis (fig. 3). The 
diagnosis of infiltrative and moderately differentiated squamous cell carcinoma was confirmed by 
histology, special colorations (MowrieD and mucicarmin) and immunohistochemical markers (p63, 
CK5–6). The patient refused surgery or chemotherapy. He was referred for palliative radiotherapy 
for pain management. 
Discussion 
ESCC was not our initial hypothesis because of our patient’s overall atypical 
presentation. First, the median age at diagnosis is 68 years with only 12% of patients 
between 45 and 54 years of age [3]. Our patient was a 53-year-old man. Second, he did 
not have dysphagia or odynophagia, which are the most common symptoms of 
esophageal cancer according to the literature [1]. His main symptom was abdominal 
pain that was also associated with postprandial abdominal fullness and vomiting. These 
were most likely due to extrinsic compression of the stomach by the abdominal mass. 
When pain is present in ESCC, it is usually thoracic or radiating to the back [1], but can 
occur less often in the upper abdomen [4]. Our patient also lost a significant amount of 
weight in 3 months – 21% of his total weight. When patients with esophageal cancer 
seek medical assistance, the majority experience anorexia and weight loss [1]. Weight 
loss seems to be an independent indicator of poor prognosis in esophageal cancer [4].  
The retropancreatic mass is also an uncommon site of metastasis in esophageal 
cancer. With the rich esophageal lymphovascular supply, lymph node metastases occur 
early in ESCC [1]. On our patient’s CT scan, the abdominal mass was not described as an 
adenopathy, but rather as a mass with heterogeneous necrotic tissue of unascertained 
origin. The initial hypotheses were gastrointestinal stromal tumor, lymphoma or 
sarcoma. A pancreatic neoplasm seemed less likely according to our radiologists. To 
our knowledge, an initial presentation of ESCC with an abdominal mass has not been 
reported, although there are few reports in the literature presenting some unusual 
metastatic presentations of ESCC, such as brain, myocardium, skin, jejunum, orbit, 
spleen, thyroid, Sister Mary Joseph’s nodule or numb chin syndrome [6–14].  
To establish the correct diagnosis of any abdominal mass, histology is indispensable 
in our opinion, especially if the patient does not present specific symptoms. Tissue 
sampling may be obtained by linear EUS [15] or by percutaneous needle biopsy under 
fluoroscopic, sonographic or CT guidance [4]. EUS provides both tissue sampling and an 
accurate evaluation of mass relationship with adjacent abdominal structures [15]. Since 
this technique is easily available in our center, we chose EUS for biopsy. Another 
important issue is that the esophageal lesion had not been identified at EUS. In our 
hospital, this procedure uses the linear scanning method that provides a limited 
wedge-shaped scanning plane. Therefore, it is possible to miss lesions if they are not in 
the scanning plane [15]. Hence, a gastroscopy was essential in the diagnosis of our 
patient’s esophageal cancer, since it provides a proper evaluation of the esophagus.  
Finally, ESCC is an aggressively invasive tumor [4]. With this large abdominal 
mass, our patient was diagnosed with a stage IV ESCC, according to the American 
Joint Committee on Cancer Staging system, rending surgery impossible [1]. The best 
treatment for our patient would have been concomitant radio-chemotherapy, which 
improves 5-year survival in 25% of patients, whereas no patients survived 5 years  
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using radiotherapy alone [16]. Our patient refused chemotherapy because of the 
possible side effects, but he accepted palliative radiotherapy to alleviate his abdominal 
pain.  
Conclusion 
To our knowledge, this is the first reported case of ESCC presenting as a large 
abdominal mass that was not an adenopathy. This case highlights that when a 
malignancy is suspected, it is important to establish a cytohistologic diagnosis. This can 
be safely achieved by EUS that will also evaluate extension of an upper abdominal mass. 
However, this technique does not replace gastroscopy to accurately identify esophageal 
cancer. 
 
 
 
 
 
 
Fig. 1. CT scanning showing the heterogeneous mass localized beneath the pancreatic gland. 
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Fig. 2. The heterogeneous mass visualized with EUS. 
 
 
 
Fig. 3. Gastroscopy showing the suspicious lesion at the mid third of the esophagus. 
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